Clinical Update in Immunoglobulin Therapy for Primary Immunodeficiency Diseases

Immunoglobulin therapy represents a life saving intervention for many patients with primary immunodeficiency disease (PIDD). While this therapy has existed and has been in use for more than 60 years, the preparations themselves and our understanding of how they are applied to patients to enhance outcomes has continually evolved. This update will focus upon the currently available immunoglobulin preparations and how they can be used to optimize patient outcomes.